Skip to main content
. 2023 Apr 27;12:106. doi: 10.4103/abr.abr_320_22

Table 1.

Studied variables in BSIs cases based on outcomes and use of the catheter in ICU wards

Variables Outcome Catheter


Discharge 238 Dead 102 P* Yes 174 No 224 P
Age (year) 55.83±18.78 57.21±16.15 0.495 55.23±18.40 56.46±18.14 0.504
Hospitalisation length (day) 47.07±44.15 47.38±64.79 0.959 63.57±65.75 38.67±39.13 <0.001
Duration between hospitalisation and incidence of BSIs (day) 29.44±39.55 37.21±62.41 0.248 53.27±79.39 24.95±36.85 <0.001
Duration between inserting catheter and incidence of BSIs (day) 28.90±31.59 33.98±39.16 0.441 - - -
Sex
 Male 138 (58.0%) 59 (57.8%) 0.981 95 (54.6%) 137 (61.2%) 0.188
 Female 100 (42.0%) 43 (42.2%) 79 (45.4%) 87 (38.8%)
Year
 2017 30 (56.6%) 23 (43.4%) <0.001 70 (40.2%) 2 (0.9%) <0.001
 2018 32 (47.8%) 35 (52.2%) 100 (57.5%) 6 (2.7%)
 2019 76 (93.8%) 5 (6.2%) 3 (1.7%) 78 (34.8%)
 2020 100 (71.9%) 39 (28.1%) 1 (0.6%) 138 (61.6%)
Catheter
 Central venous catheter 38 (44.2%) 48 (55.8%) <0.001 - - -
 Peripheral venous catheter 24 (80.00%) 6 (20.00%)
 Without catheter 176 (78.6%) 48 (21.4%)
Organism
 Acinetobacter 50 (21.0%) 36 (35.3%) 0.004 33 (19.0%) 63 (28.1%) 0.002
 Staphylococcus epidermidis** 75 (31.5%) 13 (12.7%) 29 (16.7%) 70 (31.3%)
 Enterobacter 12 (5.0%) 2 (2.0%) 10 (5.7%) 7 (3.1%)
 Pseudomonas aeruginosa 5 (2.1%) 1 (1.0%) 3 (1.7%) 4 (1.8%)
 Candida 4 (1.7%) 2 (2%) 5 (2.9%) 2 (0.9%)
 Enterococcus 18 (7.6%) 4 (3.9%) 20 (11.5%) 11 (4.9%)
 Klebsiella 58 (24.4%) 34 (33.3%) 60 (34.5%) 54 (24.1%)
 Staphylococcus aureus 8 (3.4%) 6 (5.9%) 6 (3.4%) 8 (3.6%)
 E. coli 6 (2.5%) 2 (2%) 5 (2.9%) 3 (1.3%)
 Other 2 (0.8%) 2 (2.0%) 3 (1.7%) 2 (0.9%)

*P<0.05 was considered significant. **Confirmed with two sample